Home » Policy & public » Education » Protected: Introduction to Synthetic Biology Course

Protected: Introduction to Synthetic Biology Course

March 6, 2019

Kevin Costa

As Editor and Program Manager, Kevin leads SynBioBeta's digital media content, with the goal of telling the story of the people, companies, and ideas shaping the future with biology. Before joining SynBioBeta, Kevin managed the Synthetic Biology Engineering Research Center. His interests include public engagement, science writing, community building, and bikes!

View all posts

Click here to join our weekly newsletter. We want to hear what you think about this article. Got a tip for our news team? Write to editorial@synbiobeta.com.

Protected: Introduction to Synthetic Biology Course

Kevin Costa

Riffyn and Imperial College Partner to Build Digital Foundations to Accelerate Synthetic Biology Research

Debut Biotechnology Awarded $1M from Air Force Research Lab to Leverage Cell-Free Continuous Biomanufacturing in Aerospace Applications

Ansa Biotechnologies Raises $9.2 Million in Combined Seed and Pre-Seed Financing

Evonetix and Analog Devices Collaborate on Third-Generation DNA Synthesis Platform

Editor’s picks

Could Fermentation Power The Future Of Plant-Based Foods? Motif FoodWorks Thinks Yes.

Demetrix Is Scaling The Cannabinoid Industry

The Drug Supply Chain Is Broken. A New Breakthrough Paves The Way For On-Demand Plant-Based Medicines

How Do We Safely Reopen Schools And Work? Cheap, Fast Testing, Enabled By A $5 Million XPRIZE

How A Newly Public Synthetic Biology Company Pivoted To The Pandemic: Up Close And Personal With Twist Bioscience

A Virtual Drug Discovery Company—With No Lab Of Its Own—Partners With Roche To Fight Cancers In The Brain

The Rush For Hand Sanitizers Is A Boom For Hand Moisturizers. This Startup Has A Solution For Both.

Can Technology Make More Natural Pesticides? Zymergen-FMC Partnership Offers A Peek Into The Future Of Crop Protection

More Talent Rushes To The Synthetic Biology Gold Mine: Venture Capitalist Mitchell Mutz Leaves Roche To Join Codon Capital

Automated Biology Is Now an Affordable Reality

Search Funds: A New Model for Innovation in the Synthetic Biology Industry

Two Unicorns Shaping the Future of the Synthetic Biology Industry

Your Car Is More Plastic Than You Know. This Company May Soon Be Brewing Its Parts With Biology.

Will programming a cell ever be as easy as programming an app?

A Next-Generation Infant Formula—The Closest To Mother’s Milk Yet—Made With Biology

Have your cake and eat it too, so long as they’re GMO: 5 Reasons GMO should be on your shopping list

Despite Coronavirus, 85% Of Americans Are Thinking About Sustainability As Much As Or More Than Ever

A New Test May Show Whether Your Immune System Can Neutralize The Coronavirus

Synthetic Biology Reports

Job opportunities

Videos

SynBioBeta Podcast! Hosted Live and exclusively for our Bioeconomy Hub Members.

SynBioBeta Town Hall on sequencing’s vital new role in fighting pandemics: A COVID-19 update from Illumina leadership

SynBioBeta State of the Industry Town Hall with Drew Endy

COVID-19 Town Hall with Nanome: Exploring the coronavirus spike protein in 3D virtual reality

SynBioBeta State of the Industry Town Hall with James Collins

SynBioBeta State of the Industry Town Hall with George Church

SynBioBeta COVID-19 Town Hall with JCVI’s Richard Scheuermann on coronavirus immune epitopes

COVID-19 Town Hall on Ginkgo’s $25M pledge and the community’s responses

COVID-19 Town Hall on environmental sampling for coronavirus

Protected: Introduction to Synthetic Biology Course

Kevin Costa

You may also like

Editor’s picks

Synthetic Biology Reports

Job opportunities

Videos